{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:10:24Z","timestamp":1778335824234,"version":"3.51.4"},"reference-count":35,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.5551\/jat.65980","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:07:56Z","timestamp":1761862076000},"page":"402-416","source":"Crossref","is-referenced-by-count":2,"title":["Association of Serum Soluble T-cadherin Levels with Metabolic Syndrome in Japanese Participants Undergoing Health Checkups"],"prefix":"10.5551","volume":"33","author":[{"given":"Ryohei","family":"Mineo","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"},{"name":"Department of Endocrinology and Metabolism, Sumitomo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Iioka","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Atherosclerosis, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Obata","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Physical Checkup Center, Sumitomo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sumitomo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Matsuzawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sumitomo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T and Shimamoto K. Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese Men-The Tanno and Sobetsu Study. Hypertens Res. 2005; 28: 203-208","DOI":"10.1291\/hypres.28.203"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M and Kiyohara Y. Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study. Stroke. 2007; 38: 2063-2069","DOI":"10.1161\/STROKEAHA.106.479642"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nakamura T, Tsubono Y, Kameda-Takemura K, Funahashi T, Yamashita S, Hisamichi S, Kita T, Yamamura, T and Matsuzawa Y. Magnitude of Sustained Multiple Risk Factors for Ischemic Heart Disease in Japanese Employees. Jpn Circ J. 2001; 65: 11-17","DOI":"10.1253\/jcj.65.11"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayakawa T, Kita Y, Saitoh S, Okayama, A and Ueshima H. Combined Cardiovascular Risk Factors and Outcome: NIPPON DATA80, 1980-1994. Circ J. 2006; 70: 960-964","DOI":"10.1253\/circj.70.960"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Moriyama T, Kondo M, Iseki C and Watanabe T. Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan. Intern Med. 2020; 59: 2671-2678","DOI":"10.2169\/internalmedicine.4975-20"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Neeland IJ, Ross R, Despr\u00e9s J-P, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart J-C and Eckel RH. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019; 7: 715-725","DOI":"10.1016\/S2213-8587(19)30084-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T and Matsuzawa Y. Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity. Biochem Biophys Res Commun. 1999; 257: 79-83","DOI":"10.1006\/bbrc.1999.0255"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R and Kadowaki T. Measurement of the High\u2013Molecular Weight Form of Adiponectin in Plasma Is Useful for the Prediction of Insulin Resistance and Metabolic Syndrome. Diabetes Care. 2006; 29: 1357-1362","DOI":"10.2337\/dc05-1801"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T and Node K. High Molecular Weight Adiponectin as a Predictor of Long-Term Clinical Outcome in Patients With Coronary Artery Disease. Am J Cardiol. 2007; 100: 569-574","DOI":"10.1016\/j.amjcard.2007.03.062"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hug C, Wang J, Ahmad NS, Bogan JS, Tsao T-S and Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin. Proc Natl Acad Sci U S A. 2004; 101: 10308-10313","DOI":"10.1073\/pnas.0403382101"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fukuda S, Kita S, Obata Y, Fujishima Y, Nagao H, Masuda S, Tanaka Y, Nishizawa H, Funahashi T, Takagi J, Maeda N and Shimomura I. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2. J Biol Chem. 2017; 292: 7840-7849","DOI":"10.1074\/jbc.M117.780734"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kita S, Fukuda S, Maeda N and Shimomura I. Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin. Elife. 2019; 8: e48675","DOI":"10.7554\/eLife.48675"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ranscht B and Dours-Zimmermann MT. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron. 1991; 7: 391-402","DOI":"10.1016\/0896-6273(91)90291-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fujishima Y, Maeda N, Matsuda K, Masuda S, Mori T, Fukuda S, Sekimoto R, Yamaoka M, Obata Y, Kita S, Nishizawa H, Funahashi T, Ranscht B and Shimomura I. Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis. FASEB J. 2017; 31: 1571-1583","DOI":"10.1096\/fj.201601064R"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Obata Y, Kita S, Koyama Y, Fukuda S, Takeda H, Takahashi M, Fujishima Y, Nagao H, Masuda S, Tanaka Y, Nakamura Y, Nishizawa H, Funahashi T, Ranscht B, Izumi Y, Bamba T, Fukusaki E, Hanayama R, Shimada S, Maeda N and Shimomura I. Adiponectin\/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. JCI Insight. 2018; 3: 99680","DOI":"10.1172\/jci.insight.99680"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tanaka Y, Kita S, Nishizawa H, Fukuda S, Fujishima Y, Obata Y, Nagao H, Masuda S, Nakamura Y, Shimizu Y, Mineo R, Natsukawa T, Funahashi T, Ranscht B, Fukada S-I, Maeda N and Shimomura I. Adiponectin promotes muscle regeneration through binding to T-cadherin. Sci Rep. 2019; 9: 16","DOI":"10.1038\/s41598-018-37115-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakamura Y, Kita S, Tanaka Y, Fukuda S, Obata Y, Okita T, Nishida H, Takahashi Y, Kawachi Y, Tsugawa-Shimizu Y, Fujishima Y, Nishizawa H, Takakura Y, Miyagawa S, Sawa Y, Maeda N and Shimomura I. Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice. Mol Ther. 2020; 28: 2203-2219","DOI":"10.1016\/j.ymthe.2020.06.026"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Matsuda K, Fujishima Y, Maeda N, Mori T, Hirata A, Sekimoto R, Tsushima Y, Masuda S, Yamaoka M, Inoue K, Nishizawa H, Kita S, Ranscht B, Funahashi T and Shimomura I. Positive Feedback Regulation Between Adiponectin and T-Cadherin Impacts Adiponectin Levels in Tissue and Plasma of Male Mice. Endocrinology. 2015; 156: 934-946","DOI":"10.1210\/en.2014-1618"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Fukuda S, Kita S, Miyashita K, Iioka M, Murai J, Nakamura T, Nishizawa H, Fujishima Y, Morinaga J, Oike Y, Maeda N and Shimomura I. Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum. J Clin Endocrinol Metab. 2021; 106: 1333-1344","DOI":"10.1210\/clinem\/dgab066"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Okita T, Kita S, Fukuda S, Kondo Y, Sakaue T, Iioka M, Fukuoka K, Kawada K, Nagao H, Obata Y, Fujishima Y, Ebihara T, Matsumoto H, Nakagawa S, Kimura T, Nishizawa H and Shimomura I. Soluble T-cadherin secretion from endothelial cells is regulated via insulin\/PI3K\/Akt signalling. Biochem Biophys Res Commun. 2024; 732: 150403","DOI":"10.1016\/j.bbrc.2024.150403"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Iioka M, Fukuda S, Maeda N, Natsukawa T, Kita S, Fujishima Y, Sawano H, Nishizawa H and Shimomura I. Time-Series Change of Serum Soluble T-Cadherin Concentrations and Its Association with Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction. J Atheroscler Thromb. 2022; 29: 1823-1834","DOI":"10.5551\/jat.63305"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO). EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016; 64: 1388-1402","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"23","unstructured":"23) Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. [Definition and the diagnostic standard for metabolic syndrome]. Nihon Naika Gakkai Zasshi. 2005; 94: 794-809"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ohya Y and Sakima A. JSH2025 guidelines new viewpoints. Hypertens Res. 2025; s41440-025-02296\u20138","DOI":"10.1038\/s41440-025-02296-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K and Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int. 2020; 11: 165-223","DOI":"10.1007\/s13340-020-00439-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A and Yanai H. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb. 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Okaniwa S, Hirai T, Ogawa M, Tanaka S, Inui K, Wada T, Matsumoto N, Nishimura S, Chiba Y, Onodera H, Kumada T, Kojima M, Nakajima M, Mizuma Y, Tanaka S, Nishikawa T, Mihara S, Yoda Y, Adachi, M and Atarashi T. Manual for abdominal ultrasound in cancer screening and health checkups, revised edition (2021). J Med Ultrasonics. 2023; 50: 5-49","DOI":"10.1007\/s10396-022-01272-w"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Fukuoka K, Mineo R, Kita S, Fukuda S, Okita T, Kawada-Horitani E, Iioka M, Fujii K, Kawada K, Fujishima Y, Nishizawa H, Maeda N and Shimomura I. ER stress decreases exosome production through adiponectin\/T-cadherin-dependent and -independent pathways. J Biol Chem. 2023; 299: 105114","DOI":"10.1016\/j.jbc.2023.105114"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hotamisligil GS. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease. Cell. 2010; 140: 900-917","DOI":"10.1016\/j.cell.2010.02.034"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Boddu NJ, Theus S, Luo S, Wei JY and Ranganathan G. Is the lack of adiponectin associated with increased ER\/SR stress and inflammation in the heart? Adipocyte. 2014; 3: 10-18","DOI":"10.4161\/adip.26684"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Maamoun H, Abdelsalam SS, Zeidan A, Korashy HM and Agouni A. Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes. Int J Mol Sci. 2019; 20: 1658","DOI":"10.3390\/ijms20071658"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Prola A, Nichtova Z, Pires Da Silva J, Piquereau J, Monceaux K, Guilbert A, Gressette M, Ventura-Clapier R, Garnier A, Zahradnik I, Novotova M and Lemaire C. Endoplasmic reticulum stress induces cardiac dysfunction through architectural modifications and alteration of mitochondrial function in cardiomyocytes. Cardiovasc Res. 2019; 115: 328-342","DOI":"10.1093\/cvr\/cvy197"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Libby P, Ridker PM and Maseri A. Inflammation and Atherosclerosis. Circulation. 2002; 105: 1135-1143","DOI":"10.1161\/hc0902.104353"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FGR, Hiatt WR, J\u00f6nsson B, Lacroix P, Marin B, McDermott MM, Norgren L, Pande RL, Preux P-M, (Jelle) Stoffers HE and Treat-Jacobson D. Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement From the American Heart Association. Circulation. 2012; 126: 2890-2909","DOI":"10.1161\/CIR.0b013e318276fbcb"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wassel CL, Allison MA, Ix JH, Rifkin DE, Forbang NI, Denenberg JO and Criqui MH. Ankle-brachial index predicts change over time in functional status in the San Diego Population Study. J Vasc Surg. 2016;64:656-662.e1","DOI":"10.1016\/j.jvs.2016.02.066"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65980\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:25:29Z","timestamp":1775276729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65980\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65980","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"65980"}}